Ładuje się......
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Cannabidiol (CBD)-containing products are widely marketed as over the counter products. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to acid-catalysed cyclization of CBD to psychotropic Δ (9)-tetrahydrocannabinol (Δ (9)-THC) in the st...
Zapisane w:
| Wydane w: | F1000Res |
|---|---|
| Główni autorzy: | , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
F1000 Research Limited
2024
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7029751/ https://ncbi.nlm.nih.gov/pubmed/32117565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.19931.7 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|